Want to join the conversation?
For 1Q17, $INTU expects revenue to be $740-760MM, GAAP operating loss to be $65-75MM, GAAP loss per share to be $0.19-0.21 and non-GAAP diluted EPS to be $0.01-0.03. For FY17, revenue is expected to be between $5.0-5.1Bil, GAAP operating income of $1.33-1.38Bil, GAAP diluted EPS of $3.35-3.45 & non-GAAP diluted EPS of $4.30-4.40.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?